MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Friedreich’s ataxia: A descriptive study of a Tunisian cohort

    L. Hlioui, R. Zouari, MZ. Saied, D. Ben Mohamed, A. Rachdi, R. Amouri, S. Ben Sassi (Tunis, Tunisia)

    Objective: we aim to describe the clinical, radiological and electrophysiological features of Friedreich's ataxia (FA) in our population. Background: FA is the most common autosomal…
  • 2024 International Congress

    Tremulous Machado-Joseph Disease

    V. Procaci, L. de Farias, S. da Costa, O. Barsottini, J. Pedroso (Sao Paulo, Brazil)

    Objective: To describe a case of spinocerebellar ataxia type 3 (SCA3) presenting with tremor. Background: Tremor is not a frequent manifestation in SCA3, especially as…
  • 2024 International Congress

    Progressive cerebellar ataxia in primary Sjögren’s syndrome: a case report

    T. Nguyen, V. Le, K. Vo, T. Tran (Ho Chi Minh, Viet Nam)

    Objective: To present a rare case of gradually progressing cerebellar ataxia due to systemic autoimmune disease. Background: Primary Sjögren’s syndrome (pSS) is an autoimmune disease,…
  • 2024 International Congress

    Non Classified Spinocerebellar Ataxia-like Syndrome due to GYG-1 gene mutation with TPM3, GEMIN5 and DES mutations in a Peruvian family

    W. Trillo Alvarez, A. Escalante Mercado, D. Hito Cano, L. Delgado Villanueva, K. Choque Pereyra, E. Carrillo Monteagudo, P. Gonzales Romero (Arequipa, Peru)

    Objective: To report a GYG1 mutation in a Peruvian family presenting as a non classified Spinocerebellar Ataxia (SCA) with added GEMIN5, DES and TPM3 mutations.…
  • 2024 International Congress

    paraneoplastic cerebellar ataxia: a rare cause of late-onset ataxia

    H. Boussaid, R. Zouari, D. Ben Mohamed, A. Rachdi, Z. Said, F. Nebli, S. Ben Sassi (monastir, Tunisia)

    Objective: investigate the clinical features, imaging findings and immunological characteristics of Paraneoplastic cerebellar ataxia (PCA) in our cohort. Background: Paraneoplastic cerebellar ataxia (PCA) is a…
  • 2024 International Congress

    Progressive Cerebellar Ataxia as the Predominant Symptomatology of SGP-7 Compound Heterozygote Pathogenic Variants related HSP-7

    D. Menghani, T. Yamasaki (Nicholasville, USA)

    Objective: Analyze a clinical case detailing the presentation of a patient primarily exhibiting gradual onset balance disturbances, subsequently diagnosed with HSP-7, elucidating key diagnostic challenges…
  • 2024 International Congress

    White Matter Tractography in Spinocerebellar Ataxia type 1 and 2 in comparison with Healthy Controls

    P. Pankaj, A. Srivastava, M. Kumar, S. Kumaran, A. Garg, R. Agarwal, A. Nehra (New Delhi, India)

    Objective: To assess and quantify microstructural white matter atrophy in brain of spinocerebellar ataxia (SCA) types SCA1 and SCA2 patients in comparison with healthy subjects.…
  • 2024 International Congress

    Evaluating Adaptive Devices to Assist Eating in Essential Tremor Patients: A Comparative Analysis

    K. Adabi, W. Ondo (Houston, USA)

    Objective: To evaluate the effectiveness of six adaptive devices to mitigate tremor impact while eating in patients with essential tremor (ET), compared to a standard…
  • 2024 International Congress

    Differences in regional activity levels between healthy controls, PD-nFOG, and PD-FOG as measured by ALFF and fALFF using resting-state fMRI.

    T. Davis, Z. Mari, V. Mishra (Birmingham, USA)

    Objective: To elucidate regional neural activity differences in patients with PD-FOG using resting-state fMRI (rs-fMRI). Background: Freezing of gait (FOG) in Parkinson's disease (PD0 is…
  • 2024 International Congress

    Efficacy and Safety of Amantadine in Parkinson’s Disease with Dyskinesia and Motor Fluctuations: A Systematic Review and Meta-Analysis

    S. Rujirussawarawong, S. Aungsumart, C. Kasemsuk, N. Limotai (Bangkok, Thailand)

    Objective: To evaluate the efficacy and safety of oral amantadine (AMA) compared to placebo in the treatment of dyskinesia (DYS) and motor fluctuations (MF) in…
  • « Previous Page
  • 1
  • …
  • 461
  • 462
  • 463
  • 464
  • 465
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley